feed,title,long_url,short_url
Benzinga,FDA Concerns At Catalent Site Spurred Novo Nordisk's Wegovy Supply Woes: Report,https://benzinga.com/general/biotech/22/01/25054259/fda-concerns-at-catalent-site-spurred-novo-nordisks-wegovy-supply-woes-report,https://j.mp/3GyDIhV
Benzinga,"Johnson and Johnson' COVID-19 Booster Is 85% Effective Against Omicron Hospitalization, South African Study Shows",https://benzinga.com/general/biotech/22/01/25053380/johnson-and-johnson-covid-19-booster-is-85-effective-against-omicron-hospitalization-south-africa,https://j.mp/3nmXN3a
